Login / Signup

Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass grafting in stable patients with multi-vessel coronary artery disease: From the CREDO-Kyoto PCI/CABG registry Cohort-3.

Hiroki WatanabeKo YamamotoHiroki ShiomiTakeshi MorimotoEri KatoYukiko MatsumuraKenji NakatsumaYasuaki TakejiHidenori YakuErika YamamotoYugo YamashitaYusuke YoshikawaMasayuki FukiKyohei YamajiNatsuhiko EharaHiroki SakamotoKazuaki ImadaTakeshi TadaRyoji TaniguchiRyusuke NishikawaTomohisa TadaTakashi UegaitoTatsuya OgawaMiho YamadaTeruki TakedaHiroshi EizawaNobushige TamuraKeiichi TambaraSatoru SuwaManabu ShirotaniToshihiro TamuraMoriaki InokoJunichiro NishizawaMasahiro NatsuakiHiroshi SakaiTakashi YamamotoNaoki KanemitsuNobuhisa OhnoKatsuhisa IshiiAkira MaruiHiroshi TsuneyoshiYasuhiko TeraiShogo NakayamaKazuhiro YamazakiMamoru TakahashiTakashi TamuraJiro EsakiShinji MikiTomoya OnoderaHiroshi MabuchiYutaka FurukawaMasaru TanakaTatsuhiko KomiyaYoshiharu SogaMichiya HanyuKenji AndoKazushige KadotaKenji MinatoyaYoshihisa NakagawaTakeshi Kimuranull null
Published in: PloS one (2022)
In this observational study, PCI with new-generation DES as compared with CABG was associated with excess long-term risk for major cardiovascular events in patients who underwent multi-vessel coronary revascularization including LAD.
Keyphrases